78 related articles for article (PubMed ID: 27353798)
1. Genotyping might help therapeutic decision-making in patients with von Willebrand disease type 2 B.
Rugeri L; Fretigny M; Dargaud Y; Nougier C; Vinciguerra C
Haemophilia; 2016 Sep; 22(5):e439-43. PubMed ID: 27353798
[No Abstract] [Full Text] [Related]
2. Characterisation of the p.A1461D mutation causing von Willebrand disease type 2B with severe thrombocytopenia, circulating giant platelets, and defective α-granule secretion.
Langer F; Obser T; Oyen F; Spath B; Holstein K; Greinacher A; White JG; Budde U; Bokemeyer C; Schneppenheim R
Thromb Haemost; 2014 Apr; 111(4):777-9. PubMed ID: 24337418
[No Abstract] [Full Text] [Related]
3. Thrombin generation in the presence of platelets is sensitive to the activation status of von Willebrand factor.
Pelkmans L; Miszta A; Al Dieri R; de Laat B; Kelchtermans H
Thromb Haemost; 2015 Jan; 113(1):209-11. PubMed ID: 25274249
[No Abstract] [Full Text] [Related]
4. Type 2B von Willebrand Disease: A Matter of Plasma Plus Platelet Abnormality.
Castaman G; Federici AB
Semin Thromb Hemost; 2016 Jul; 42(5):478-82. PubMed ID: 27148840
[TBL] [Abstract][Full Text] [Related]
5. An update on type 2B von Willebrand disease.
Mikhail S; Aldin ES; Streiff M; Zeidan A
Expert Rev Hematol; 2014 Apr; 7(2):217-31. PubMed ID: 24521271
[TBL] [Abstract][Full Text] [Related]
6. Differential diagnosis between type 2A and 2B von Willebrand disease in a child with a previously undescribed de novo mutation.
Pagliari MT; Baronciani L; Stufano F; Colpani P; Siboni SM; Peyvandi F
Haemophilia; 2018 Jul; 24(4):e263-e266. PubMed ID: 30044032
[No Abstract] [Full Text] [Related]
7. Biomedicine. Contact--how platelets touch von Willebrand factor.
Sadler JE
Science; 2002 Aug; 297(5584):1128-9. PubMed ID: 12183613
[No Abstract] [Full Text] [Related]
8. False normal von Willebrand factor activity by monoclonal antibody-based ELISA in a patient with type 2A(IID) von Willebrand disease.
Ahmad S; Ptashkin B; DiGiovanni C; Cines DB; Konkle BA; Cuker A
Thromb Haemost; 2011 Dec; 106(6):1224-5. PubMed ID: 21979291
[No Abstract] [Full Text] [Related]
9. A role for von Willebrand factor in Streptococcus sanguis-induced platelet activation.
McNicol A; Eyer E; Jackson EC; Israels SJ
Thromb Haemost; 2007 Dec; 98(6):1382-4. PubMed ID: 18064343
[No Abstract] [Full Text] [Related]
10. Platelet abnormalities in a family with von Willebrand disease type 2B (V1316M) and association with bleeding score.
Guglielmone HA; Smith N; Minoldo S; Jarchum GD; White-Adams T; Di Paola J
Haemophilia; 2016 Sep; 22(5):e455-8. PubMed ID: 27385556
[No Abstract] [Full Text] [Related]
11. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
[TBL] [Abstract][Full Text] [Related]
12. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
[TBL] [Abstract][Full Text] [Related]
13. A second report of platelet-type von Willebrand disease with a Gly233Ser mutation in the GPIBA gene.
Nurden P; Lanza F; Bonnafous-Faurie C; Nurden A
Thromb Haemost; 2007 Feb; 97(2):319-21. PubMed ID: 17264965
[No Abstract] [Full Text] [Related]
14. Identification of a new type 2M von Willebrand disease mutation also at position 1324 of von Willebrand factor.
Hilbert L; Fressinaud E; Ribba AS; Meyer D; Mazurier C;
Thromb Haemost; 2002 Apr; 87(4):635-40. PubMed ID: 12008946
[TBL] [Abstract][Full Text] [Related]
15. Acquired von Willebrand syndrome type 2A in a JAK2-positive essential thrombocythaemia-affected member of a large von Willebrand disease family with a novel autosomal dominant A1716P mutation.
Giannini S; Solimando M; Fierro T; Baronciani L; Federici AB; Gresele P
Thromb Haemost; 2011 May; 105(5):921-4. PubMed ID: 21359411
[No Abstract] [Full Text] [Related]
16. A novel use of thromboelastography in type 2B von Willebrand disease.
Toukh M; Ozelo MC; Angelillo-Scherrer A; Othman M
Int J Lab Hematol; 2013 Dec; 35(6):e11-4. PubMed ID: 23621544
[No Abstract] [Full Text] [Related]
17. Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children.
Frontroth JP; Hepner M; Sciuccati G; Feliú Torres A; Pieroni G; Bonduel M
Thromb Haemost; 2010 Dec; 104(6):1158-65. PubMed ID: 20941465
[TBL] [Abstract][Full Text] [Related]
18. Quantitative and qualitative analysis of platelet GPIb and von Willebrand factor in liver cirrhosis.
Beer JH; Clerici N; Baillod P; von Felten A; Schlappritzi E; Büchi L
Thromb Haemost; 1995 Apr; 73(4):601-9. PubMed ID: 7495066
[TBL] [Abstract][Full Text] [Related]
19. Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor.
Hilbert L; Jenkins PV; Gaucher C; Meriane E; Collins PW; Pasi KJ; Mazurier C
Thromb Haemost; 2000 Aug; 84(2):188-94. PubMed ID: 10959688
[TBL] [Abstract][Full Text] [Related]
20. Platelet GPIb: sensing force and responding.
Ruggeri ZM
Blood; 2015 Jan; 125(3):423-4. PubMed ID: 25593332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
